YANKCOM Partnership’s Bristol-Myers Squibb BMY Stock Holding History

YANKCOM Partnership’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.6K	Hold	322	–	–	0.01%	233
2026 Q1	$19.5K	Hold	322	–	–	0.01%	229
2025 Q4	$17.4K	Hold	322	–	–	0.01%	249
2025 Q3	$14.5K	Buy	322 +40	+14%	+$1.87K	0.01%	228
2025 Q2	$13.1K	Hold	282	–	–	0.01%	225
2025 Q1	$17.2K	Sell	282 -45	-14%	-$2.62K	0.01%	216
2024 Q4	$18.5K	Buy	+327	New	+$18.3K	0.01%	211

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

YANKCOM Partnership's BMY Position: Q2 2026 in Review

YANKCOM Partnership held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 322 shares worth $18.6K. The position accounts for 0.01% of the portfolio, ranked #233.

YANKCOM Partnership first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $19.5K in Q1 2026. 964 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

YANKCOM Partnership held 322 shares of Bristol-Myers Squibb worth $18.6K as of Q2 2026.
YANKCOM Partnership left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.01% of YANKCOM Partnership's portfolio in Q2 2026, its #233 holding.
YANKCOM Partnership first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
YANKCOM Partnership's Bristol-Myers Squibb position peaked at $19.5K in Q1 2026.
964 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.